Alexion Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ALXN
CUSIP
015351109
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 1 6.94 k $924 k
2023 Q4 1 61.0 $8.83 k
2023 Q3 1 61.0 $10.4 k
2023 Q2 1 61.0 $13.6 k
2023 Q1 1 61.0 $13.0 k
2022 Q4 1 61.0 $13.0 k
2022 Q3 1 61.0 $16.0 k
2022 Q2 1 60.0 $13.0 k
2022 Q1 1 60.0 $13.0 k
2021 Q4 2 86.0 $14.0 k
2021 Q3 7 5.80 k $845 k
2021 Q2 738 212 M $39.1 B
2021 Q1 792 205 M $31.3 B
2020 Q4 880 202 M $31.7 B
2020 Q3 765 200 M $22.8 B
2020 Q2 753 201 M $22.5 B
2020 Q1 727 202 M $18.1 B
2019 Q4 729 207 M $22.4 B
2019 Q3 714 208 M $20.4 B
2019 Q2 703 214 M $28.2 B
2019 Q1 673 216 M $29.2 B
2018 Q4 662 215 M $20.9 B
2018 Q3 643 220 M $30.6 B
2018 Q2 656 214 M $26.5 B
2018 Q1 660 212 M $23.6 B
2017 Q4 648 212 M $25.3 B
2017 Q3 650 214 M $30.1 B
2017 Q2 613 214 M $26.0 B
2017 Q1 608 215 M $26.0 B
2016 Q4 607 220 M $26.9 B
2016 Q3 561 217 M $26.6 B
2016 Q2 587 218 M $25.4 B
2016 Q1 560 226 M $30.5 B
2015 Q4 590 225 M $42.9 B
2015 Q3 553 225 M $35.1 B
2015 Q2 597 220 M $39.8 B
2015 Q1 604 193 M $33.5 B
2014 Q4 612 194 M $35.9 B
2014 Q3 560 192 M $33.5 B
2014 Q2 557 194 M $30.4 B
2014 Q1 531 191 M $29.0 B